ACTIVE

GlaxoSmithKline Biologicals

Export PDF

Financial year 2025 · closed on 31/12/2025

Net result

2,4 Md €

+9.3% YoY

Revenue

7,4 Md €

-5.4% YoY

Equity

10,0 Md €

-24.9% YoY

Workforce

8 371,0 ETP

-3.6% YoY

What does GlaxoSmithKline Biologicals do?

GlaxoSmithKline Biologicals is a Public limited company incorporated in 1990. Its main activity is: Manufacture of pharmaceutical preparations. Its registered office is in Rixensart. It employs on average 8 371,0 ETP workers (FTE).

Legal situation

● Normal situation

BCE/KBO no. / VAT

BE 0440.872.918

Incorporation

01/07/1990

Legal form

Public limited company

Registered office

Rue de l'Institut 89
1330 Rixensart · WallonieSee on map

Contributed capital

8 379 632 620,82 €

Latest accounts

31/12/2025

Average workforce

8 371,0 ETP

Activities (NACE)

21201Manufacture of pharmaceutical preparations· main 21201Manufacture of pharmaceutical preparations 24421Aluminium production

Joint committees (3)

Signals

ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDAHigh revenue

View the BCE/KBO Public Search record →

Health score

Available with a Rovalta subscriptionTry for 7 days

Recommended credit limit

✦ Verdict · Analyst summary

Financials

Trend over 15 financial years

	2025		2024		2023		2022		2021		2020		2019		2018		2017		2016		2015		2014		2013		2012		2011
Income statement
Revenue	7,4 Md €	-5.4%	7,9 Md €	-11.2%	8,9 Md €	+23.7%	7,2 Md €	+45.6%	4,9 Md €	-24.0%	6,5 Md €	-4.6%	6,8 Md €	+44.6%	4,7 Md €	+5.3%	4,5 Md €	+8.5%	4,1 Md €	+29.2%	3,2 Md €	+7.9%	2,9 Md €	+5.3%	2,8 Md €	+6.1%	2,6 Md €	+0.9%	2,6 Md €
EBITDA	4,5 Md €	+15.8%	3,9 Md €	-21.7%	4,9 Md €	+34.5%	3,7 Md €	+79.4%	2,0 Md €	-36.9%	3,2 Md €	-4.5%	3,4 Md €	+59.7%	2,1 Md €	+47.2%	1,4 Md €	-5.4%	1,5 Md €	+60.9%	946,1 M €	-5.6%	1,0 Md €	-0.6%	1,0 Md €	+10.1%	915,9 M €	-2.0%	934,3 M €
Operating result	2,6 Md €	+16.4%	2,3 Md €	-29.7%	3,2 Md €	+66.5%	1,9 Md €	+346%	431,9 M €	-76.1%	1,8 Md €	-17.2%	2,2 Md €	+314%	528,6 M €	+335%	-225,3 M €	+51.6%	-465,7 M €	-1633%	30,4 M €	-69.0%	97,9 M €	-27.6%	135,3 M €	-15.5%	160,2 M €	-63.7%	441,5 M €
Net result	2,4 Md €	+9.3%	2,2 Md €	-30.9%	3,2 Md €	+63.3%	1,9 Md €	+326%	455,6 M €	-74.4%	1,8 Md €	-10.6%	2,0 Md €	+286%	515,2 M €	+297%	-261,8 M €	+39.1%	-429,6 M €	-559%	93,6 M €	+495%	15,7 M €	-91.4%	182,6 M €	-26.8%	249,4 M €	-56.8%	577,1 M €
Balance sheet
Equity	10,0 Md €	-24.9%	13,3 Md €	-24.8%	17,7 Md €	+21.0%	14,6 Md €	+12.5%	13,0 Md €	-26.7%	17,7 Md €	+0.7%	17,6 Md €	+12.2%	15,7 Md €	+2.8%	15,2 Md €	-2.2%	15,6 Md €	-3.2%	16,1 Md €	+18.1%	13,6 Md €	+0.1%	13,6 Md €	+1.4%	13,4 Md €	+1.9%	13,2 Md €
Total assets	17,8 Md €	-1.5%	18,1 Md €	-9.5%	20,0 Md €	+15.2%	17,4 Md €	-15.8%	20,6 Md €	+1.1%	20,4 Md €	+3.3%	19,7 Md €	+11.8%	17,6 Md €	-0.6%	17,8 Md €	+1.4%	17,5 Md €	-2.4%	17,9 Md €	+17.9%	15,2 Md €	+1.9%	14,9 Md €	+1.0%	14,8 Md €	+1.3%	14,6 Md €
Cash	21,7 k €	-99.9%	15,4 M €	-20.2%	19,2 M €	-11.3%	21,7 M €	-49.9%	43,3 M €	+10.3%	39,2 M €	+66.4%	23,6 M €	+260%	6,6 M €	+39.8%	4,7 M €	-60.3%	11,8 M €	+1167%	931,9 k €	-82.0%	5,2 M €	-59.1%	12,6 M €	+209%	4,1 M €	-79.9%	20,3 M €
Debts	7,2 Md €	+72.2%	4,2 Md €	+174%	1,5 Md €	-15.4%	1,8 Md €	-72.5%	6,6 Md €	+341%	1,5 Md €	+5.7%	1,4 Md €	+7.4%	1,3 Md €	-24.3%	1,7 Md €	+35.1%	1,3 Md €	-0.8%	1,3 Md €	+18.8%	1,1 Md €	+10.9%	980,0 M €	+0.8%	971,8 M €	-19.7%	1,2 Md €
Other
Workforce	8 371,0 ETP	-3.6%	8 681,2 ETP	-0.2%	8 701,2 ETP	+1.8%	8 544,0 ETP	+1.6%	8 409,2 ETP	-3.9%	8 753,3 ETP	-1.5%	8 882,5 ETP	-1.0%	8 968,3 ETP	+3.8%	8 643,9 ETP	+3.1%	8 387,4 ETP	-1.0%	8 474,2 ETP	+3.2%	8 212,1 ETP	+6.7%	7 696,7 ETP	+3.6%	7 425,7 ETP	+2.4%	7 251,8 ETP

Estimate

Indicative valuation

As an indication, this company is worth

more than 1.000 M€

See the valuation

Governance

Board of directors

Seen on filing of 31/12/2025 · 10 active · 133 ended

Active mandates

Dominique DESCAMPS

Director · since 02 avril 2026 · until 24 juin 2026

Active

Cristelle NOIRHOMME

Director · since 03 septembre 2025 · until 24 juin 2026

Active

Aglaé VAN GOETHEM

Director · since 25 juin 2025 · until 24 juin 2026

Active

Benoît ALSTEENS

Director · since 25 juin 2025 · until 24 juin 2026

Active

Emmanuel AMORY

Managing director · since 25 juin 2025 · until 03 septembre 2025

Active

Emmanuel FELIX

Managing director · since 25 juin 2025 · until 24 juin 2026

Active

Irène RAPILLY

Director · since 25 juin 2025 · until 24 juin 2026

Active

Jamila LOUAHED

Managing director · since 25 juin 2025 · until 31 mars 2026

Active

Pascal LEGRAIVE

Director · since 25 juin 2025 · until 24 juin 2026

Active

Regis SIMARD

Director · since 25 juin 2025 · until 24 juin 2026

Active

Ended mandates

Aglaé VAN GOETHEM

Director · since 26 juin 2024 · until 25 juin 2025

Ended

Benoît ALSTEENS

Director · since 26 juin 2024 · until 25 juin 2025

Ended

Emmanuel AMORY

Managing director · since 26 juin 2024 · until 25 juin 2025

Ended

Irène RAPILLY

Director · since 26 juin 2024 · until 25 juin 2025

Ended

Annual accounts

Full financial information

	2025	2024	2023	2022	2021	2020
Type of account	Full model	Full model	Full model	Full model	Full model	Full model
Start of the financial year	01/01/2025	01/01/2024	01/01/2023	01/01/2022	01/01/2021	01/01/2020
Closing of the financial year	31/12/2025	31/12/2024	31/12/2023	31/12/2022	31/12/2021	31/12/2020
Length of the financial year	12 months	12 months	12 months	12 months	12 months	12 months
Filing date	10/07/2026	02/07/2025	29/07/2024	06/07/2023	20/07/2022	15/07/2021
General meeting	24/06/2026	25/06/2025	26/06/2024	28/06/2023	22/06/2022	23/06/2021
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Ratios

Financial ratios

Looking for more information about this company?

Try for 7 days

Filings

Annual accounts filings

22 filings with the NBB

Model	Closing	General meeting	Filed	Language	Document
Full model	31/12/2025	24/06/2026	10/07/2026	French	PDF
m90-f	31/12/2025	—	30/06/2026	French	PDF
Full model	31/12/2024	25/06/2025	02/07/2025	French	PDF
Full model	31/12/2023	26/06/2024	29/07/2024	French	PDF
Full model	31/12/2022	28/06/2023	06/07/2023	French	PDF
Full model	31/12/2021	22/06/2022	20/07/2022	French	PDF
Full model	31/12/2020	23/06/2021	15/07/2021	French	PDF
Full model	31/12/2019	24/06/2020	30/07/2020	French	PDF
Full model	31/12/2018	26/06/2019	17/07/2019	French	PDF
Full model	31/12/2017	27/06/2018	02/07/2018	French	PDF
Full model	31/12/2016	28/06/2017	11/07/2017	French	PDF
Full model	31/12/2015	20/07/2016	26/07/2016	French	PDF
Full model	31/12/2014	24/06/2015	08/07/2015	French	PDF
Full model	31/12/2013	25/06/2014	30/06/2014	French	PDF
Full model	31/12/2012	26/06/2013	09/09/2013	French	PDF
Full model	31/12/2011	27/06/2012	13/07/2012	French	PDF
Full model	31/12/2010	22/06/2011	19/07/2011	French	PDF
Full model	31/12/2009	23/06/2010	26/08/2010	French	PDF
Full modelCorrection	31/12/2008	24/06/2009	22/09/2009	French	PDF
Full model	31/12/2008	24/06/2009	16/07/2009	French	PDF
Full model	31/12/2007	25/06/2008	18/07/2008	French	PDF
Full model	31/12/2006	27/06/2007	19/07/2007	French	PDF

Estimate

Indicative valuation

Order of magnitude

As an indication, this company is worth

more than 1.000 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Governance

Board of directors

Seen on filing of 31/12/2025 · 10 active · 133 ended

Active mandates

Dominique DESCAMPS

Director · since 02 avril 2026 · until 24 juin 2026

Active

Cristelle NOIRHOMME

Director · since 03 septembre 2025 · until 24 juin 2026

Active

Aglaé VAN GOETHEM

Director · since 25 juin 2025 · until 24 juin 2026

Active

Benoît ALSTEENS

Director · since 25 juin 2025 · until 24 juin 2026

Active

Emmanuel AMORY

Managing director · since 25 juin 2025 · until 03 septembre 2025

Active

Emmanuel FELIX

Managing director · since 25 juin 2025 · until 24 juin 2026

Active

Irène RAPILLY

Director · since 25 juin 2025 · until 24 juin 2026

Active

Jamila LOUAHED

Managing director · since 25 juin 2025 · until 31 mars 2026

Active

Pascal LEGRAIVE

Director · since 25 juin 2025 · until 24 juin 2026

Active

Regis SIMARD

Director · since 25 juin 2025 · until 24 juin 2026

Active

Ended mandates

Aglaé VAN GOETHEM

Director · since 26 juin 2024 · until 25 juin 2025

Ended

Benoît ALSTEENS

Director · since 26 juin 2024 · until 25 juin 2025

Ended

Emmanuel AMORY

Managing director · since 26 juin 2024 · until 25 juin 2025

Ended

Irène RAPILLY

Director · since 26 juin 2024 · until 25 juin 2025

Ended

Shareholders

Ownership and network

Looking for more information about this company?

Try for 7 days

Belgian Official Gazette

Belgian Official Gazette publications

Mandates08/06/2026
DEMISSIONS, NOMINATIONS
PDF
Mandates05/11/2025
DEMISSIONS, NOMINATIONS
PDF
Mandates03/09/2025
DEMISSIONS, NOMINATIONS
PDF
Mandates30/07/2025
DEMISSIONS, NOMINATIONS
PDF
Mandates05/08/2024
DEMISSIONS, NOMINATIONS
PDF
Mandates03/07/2024
DEMISSIONS, NOMINATIONS
PDF
Mandates07/02/2024
DEMISSIONS, NOMINATIONS
PDF
Mandates03/11/2023
DEMISSIONS, NOMINATIONS
PDF

Source: Belgian Official Gazette

Competition

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

02/04/2026
nominationDominique Descamps — administrateur
02/04/2026
nominationPhilippe Denoel — gestion journalière du site de Rixensart
2025
Annual accounts 20252,4 Md €↑
03/09/2025
nominationChristelle Noirhomme — administrateur
03/09/2025
nominationEmmanuel Felix — administrateur délégué
03/09/2025
nominationJamila Louahed — administrateur délégué
01/07/2025
nominationEmmanuel Amory — gestion journalière
25/06/2025
reconductionIrene Rapilly — administrateur
25/06/2025
reconductionAglaé Van Goethem — administrateur
25/06/2025
reconductionJamila Louahed — administrateur
25/06/2025
reconductionRegis Simard — administrateur
25/06/2025
reconductionEmmanuel Amory — administrateur
25/06/2025
reconductionBenoit Alsteens — administrateur
25/06/2025
reconductionPascal Legraive — administrateur
25/06/2025
nominationEmmanuel Félix — administrateur
2024
Annual accounts 20242,2 Md €↓
01/07/2024
nominationEmmanuel Amory — gestion journalière
26/06/2024
reconductionIrene Rapilly — administrateur
26/06/2024
reconductionJamila Louahed — administrateur
26/06/2024
reconductionAglaé Van Goethem — administrateur
26/06/2024
reconductionRegis Simard — administrateur
26/06/2024
reconductionEmmanuel Amory — administrateur
26/06/2024
reconductionBenoit Alsteens — administrateur
26/06/2024
reconductionPascal Legraive — administrateur
26/06/2024
reconductionGert Vanhees — commissaire
2023
Annual accounts 20233,2 Md €↑
22/11/2023
nominationAglaé Van Goethem — administrateur
28/06/2023
reconductionBenoit Alsteens — administrateur
28/06/2023
reconductionEmmanuel Amory — administrateur
28/06/2023
reconductionPascal Legraive — administrateur
28/06/2023
reconductionAntoon Loomans — administrateur
28/06/2023
reconductionJamila Louahed — administrateur
28/06/2023
reconductionIrène Rapilly — administrateur
28/06/2023
reconductionRegis Simard — administrateur
10/01/2023
nominationRegis Simard — administrateur
10/01/2023
nominationBenoît Alsteens — administrateur
10/01/2023
nominationPascal Legraive — administrateur
10/01/2023
nominationJamila Louahed — administrateur
2022
Annual accounts 20221,9 Md €↑
22/06/2022
reconductionRoger Connor — administrateur
22/06/2022
reconductionEmmanuel Amory — administrateur
22/06/2022
reconductionAntoon Loomans — administrateur
22/06/2022
reconductionGabriel Millan — administrateur
22/06/2022
reconductionIrène Rapilly — administrateur
07/05/2022
nominationEmmanuel Amory — administrateur délégué
22/04/2022
nominationEmmanuel Amory — administrateur
2021
Annual accounts 2021455,6 M €↓
2021
Name changeGLAXOSMITHKLINE BIOLOGICALS, EN ABREGE : GSK BIOLOGICALS ou SMITHKLINE BEECHAM BIOLOGICALS
2020
Annual accounts 20201,8 Md €↓
2019
Annual accounts 20192,0 Md €↑
2018
Annual accounts 2018515,2 M €↑
2017
Annual accounts 2017-261,8 M €↑
2016
Annual accounts 2016-429,6 M €↓
2015
Annual accounts 201593,6 M €↑
2014
Annual accounts 201415,7 M €↓
2013
Annual accounts 2013182,6 M €↓
2012
Annual accounts 2012249,4 M €↓
2011
Annual accounts 2011577,1 M €
2011
Name changeGlaxoSmithKline Biologicals
01/07/1990
IncorporationPublic limited company

10/15	1 240 000	1 180 000	1 050 000
70	8 630 000	8 120 000	7 940 000
9904	412 000	388 000	301 000
17/49	2 970 000	3 140 000	3 380 000
9087	24,3	23,1	21,8

GlaxoSmithKline Biologicals

Overview

What does GlaxoSmithKline Biologicals do?

Trend over 15 financial years

Indicative valuation

Board of directors

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline